The Virtual Cell Pharmacology Initiative (VCPI) is an open source platform designed to build a standardized framework for virtual cell models.

Novartis’ $23 billion investment in U.S.-based infrastructure over the next five years is designed to increase manufacturing capacity.

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

New live-cell DNA damage sensor lets scientists watch repair unfold in real time, potentially opening doors for cancer and aging research.

In a study in IBD patients, scientists observed shifts in gut chemistry, among other changes, that could lead to new treatment strategies.

The study evaluates the long-term cognitive abilities in the mice with over expression of Sox9 or elimination of the gene.

The Fugaku supercomputer builds a highly detailed virtual mouse cortex with millions of neurons enabling unprecedented ...

PERT edits the genome to permanently express a suppressor tRNA, so that cells affected by nonsense mutations can produce functional protein.

Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...

Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...

MagGel-BS platform addresses challenges related to the targeted delivery and subsequent recovery of engineered bacteria within the GI tract.